Amedeo Smart

Free Medical Literature Service



Liver Diseases

  Free Subscription

Articles published in
    August 2021
  1. ZHANG T, Zhang G, Deng X, Zeng J, et al
    APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Radiology. 2021 Aug 24:204700. doi: 10.1148/radiol.2021204700.
    >> Share

  2. SHI Y, Qi YF, Lan GY, Wu Q, et al
    Three-dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C.
    Radiology. 2021 Aug 10:202804. doi: 10.1148/radiol.2021202804.
    >> Share

    July 2021
  3. LEE DH, Lee MW, Kim PN, Lee YJ, et al
    Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
    Radiology. 2021 Jul 27:210309. doi: 10.1148/radiol.2021210309.
    >> Share

  4. HE KS, Fernando R, Cabrera T, Valenti D, et al
    Hepatic Hilar Nerve Block for Hepatic Interventions: Anatomy, Technique, and Initial Clinical Experience in Thermal Ablation of Liver Tumors.
    Radiology. 2021 Jul 13:203410. doi: 10.1148/radiol.2021203410.
    >> Share

  5. KRINSKY G, Shanbhogue K
    Proliferative versus Nonproliferative Hepatocellular Carcinoma: Clinical and Imaging Implications.
    Radiology. 2021 Jul 6:211316. doi: 10.1148/radiol.2021211316.
    >> Share

  6. KANG HJ, Kim H, Lee DH, Hur BY, et al
    Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Radiology. 2021 Jul 6:204352. doi: 10.1148/radiol.2021204352.
    >> Share

    June 2021
  7. JIANG H, Chen HC, Lafata KJ, Bashir MR, et al
    Week 4 Liver Fat Reduction on MRI as an Early Predictor of Treatment Response in Participants with Nonalcoholic Steatohepatitis.
    Radiology. 2021 Jun 1:204325. doi: 10.1148/radiol.2021204325.
    >> Share

  8. DU J, Bydder GM
    Brain Atrophy Is a Better Biomarker than Susceptibility for Evaluating Clinical Severity in Wilson Disease.
    Radiology. 2021;299:673-674.
    >> Share

    May 2021
  9. BAI XM, Cui M, Yang W, Wang H, et al
    The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Radiology. 2021 May 18:200153. doi: 10.1148/radiol.2021200153.
    >> Share

  10. YOON JH, Kim H
    CT Characterization of Aggressive Macrotrabecular-Massive Hepatocellular Carcinoma: A Step Forward to Personalized Medicine.
    Radiology. 2021 May 11:210379. doi: 10.1148/radiol.2021210379.
    >> Share

  11. FENG Z, Li H, Zhao H, Jiang Y, et al
    Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
    Radiology. 2021 May 11:203614. doi: 10.1148/radiol.2021203614.
    >> Share

  12. MEIJERINK MR, Ruarus AH, Vroomen LGPH, Puijk RS, et al
    Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Radiology. 2021;299:470-480.
    >> Share

    April 2021
  13. PAISANT A, Gillard M, Oberti F, Roux M, et al
    Validation of a Diagnostic Algorithm for Hepatocellular Carcinoma at Gadoxetic Acid-enhanced MRI.
    Radiology. 2021 Apr 27:204529. doi: 10.1148/radiol.2021204529.
    >> Share

  14. LV J, Xu Y, Xu L, Nie L, et al
    Quantitative Functional Evaluation of Liver Fibrosis in Mice with Dynamic Contrast-enhanced Photoacoustic Imaging.
    Radiology. 2021 Apr 27:204134. doi: 10.1148/radiol.2021204134.
    >> Share

  15. LUZ JHM, Veloso Gomes F, Costa NV, Vasco I, et al
    BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils.
    Radiology. 2021 Apr 6:204055. doi: 10.1148/radiol.2021204055.
    >> Share

    March 2021
  16. O'SHEA A, Pierce TT
    US Elastography in Hepatic Fibrosis-Radiology In Training.
    Radiology. 2021 Mar 23:203893. doi: 10.1148/radiol.2021203893.
    >> Share

  17. DUSEK P, Lescinskij A, Ruzicka F, Acosta-Cabronero J, et al
    Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
    Radiology. 2021 Mar 23:202846. doi: 10.1148/radiol.2021202846.
    >> Share

  18. BAE JS, Lee JM, Yoon JH, Kang HJ, et al
    Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
    Radiology. 2021 Mar 2:203537. doi: 10.1148/radiol.2021203537.
    >> Share

  19. BASHIR MR, Mendiratta-Lala M
    CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.
    Radiology. 2021 Mar 2:210049. doi: 10.1148/radiol.2021210049.
    >> Share

    February 2021
    LI-RADS Version 2018 Is of Limited Use in the Diagnosis of Hepatocellular Carcinoma in Children.
    Radiology. 2021 Feb 23:204480. doi: 10.1148/radiol.2021204480.
    >> Share

  21. KHANNA G, Chavhan GB, Schooler GR, Fraum TJ, et al
    Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma.
    Radiology. 2021 Feb 23:203559. doi: 10.1148/radiol.2021203559.
    >> Share

  22. NARDELLI S, Riggio O, Turco L, Gioia S, et al
    Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis.
    Radiology. 2021 Feb 2:203051. doi: 10.1148/radiol.2021203051.
    >> Share

    Portosystemic Shunts: Should We Pay Closer Attention with Cross-Sectional Imaging?
    Radiology. 2021 Feb 2:204282. doi: 10.1148/radiol.2021204282.
    >> Share

    January 2021
    Normal Fetal Umbilical, Portal, and Hepatic Venous System: Four-dimensional STIC Rendering.
    Radiology. 2021 Jan 26:203300. doi: 10.1148/radiol.2021203300.
    >> Share

  25. MADOFF DC, Cornman-Homonoff J, Fortune BE, Gaba RC, et al
    Management of Refractory Ascites Due to Portal Hypertension: Current Status.
    Radiology. 2021 Jan 26:201960. doi: 10.1148/radiol.2021201960.
    >> Share

  26. CHEN S, Peng Z, Zhang Y, Chen M, et al
    Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?
    Radiology. 2021 Jan 19:202289. doi: 10.1148/radiol.2021202289.
    >> Share

    US Microbubbles as Smart Sensors of Portal Venous Pressure.
    Radiology. 2021;298:112-113.
    >> Share

  28. HAN K, Kim JH, Yang SG, Park SH, et al
    A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Radiology. 2021;298:212-218.
    >> Share

  29. KANG TW, Jeong WK, Kim YY, Min JH, et al
    Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia.
    Radiology. 2021;298:82-90.
    >> Share

    December 2020
  30. EISENBREY JR, Forsberg F, Wessner CE, Delaney LJ, et al
    US-triggered Microbubble Destruction for Augmenting Hepatocellular Carcinoma Response to Transarterial Radioembolization: A Randomized Pilot Clinical Trial.
    Radiology. 2020 Dec 15:202321. doi: 10.1148/radiol.2020202321.
    >> Share

    November 2020
  31. ROSTAMBEIGI N, Farsad K, Young S, Shrestha P, et al
    Lower-Extremity Edema Is Common after Transjugular Intrahepatic Portosystemic Shunt Creation and Is Associated with Lower Survival: A Two-Institution Study.
    Radiology. 2020 Nov 17:201690. doi: 10.1148/radiol.2020201690.
    >> Share

  32. GUPTA I, Eisenbrey JR, Machado P, Stanczak M, et al
    Diagnosing Portal Hypertension with Noninvasive Subharmonic Pressure Estimates from a US Contrast Agent.
    Radiology. 2020 Nov 17:202677. doi: 10.1148/radiol.2020202677.
    >> Share

  33. FRULIO N, Balabaud C, Trillaud H, Bioulac-Sage P, et al
    Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
    Radiology. 2020 Nov 10:203244. doi: 10.1148/radiol.2020203244.
    >> Share

  34. SOULEN MC, Sofocleous CT
    Achieving Curative Ablation Outcomes: It Is All about the Imaging.
    Radiology. 2020 Nov 10:203930. doi: 10.1148/radiol.2020203930.
    >> Share

    October 2020
    Recent Advances in US Vascular Imaging: Highlighting an Important Use Case.
    Radiology. 2020 Oct 27:203830. doi: 10.1148/radiol.2020203830.
    >> Share

    Patient Triage for Resection of Metastatic Colorectal Cancer to the Liver: Can We Do Better Using MRI?
    Radiology. 2020 Oct 6:203631. doi: 10.1148/radiol.2020203631.
    >> Share

  37. NAKAI Y, Gonoi W, Kurokawa R, Nishioka Y, et al
    MRI Findings of Liver Parenchyma Peripheral to Colorectal Liver Metastasis: A Potential Predictor of Long-term Prognosis.
    Radiology. 2020 Oct 6:202367. doi: 10.1148/radiol.2020202367.
    >> Share

  38. DAVARPANAH AH, Eberhardt LW
    Case 282: Fishbone Pylephlebitis.
    Radiology. 2020;297:239-243.
    >> Share

  39. DE ROOS A, Lamb HJ
    Exploring the Interaction between Liver and Heart Disease.
    Radiology. 2020;297:62-63.
    >> Share

  40. WEISS CR, Nezami N
    One Step Closer to Precision Medicine for Transarterial Therapy of HCC.
    Radiology. 2020;297:235-236.
    >> Share

    September 2020
  41. TANG A
    Using MRI to Assess Microvascular Invasion in Hepatocellular Carcinoma.
    Radiology. 2020 Sep 29:203376. doi: 10.1148/radiol.2020203376.
    >> Share

  42. WANG F, Numata K, Ruan L
    Accurate Assessment of Vascularity of Focal Hepatic Lesions in Arterial Phase Imaging.
    Radiology. 2020 Sep 29:202780. doi: 10.1148/radiol.2020202780.
    >> Share

  43. MIN JH, Lee MW, Park HS, Lee DH, et al
    Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
    Radiology. 2020 Sep 29:201940. doi: 10.1148/radiol.2020201940.
    >> Share

  44. DO RK, Mendiratta-Lala M
    Moving Away from Uncertainty: A Potential Role for Ancillary Features in LI-RADS Treatment Response.
    Radiology. 2020;296:562-563.
    >> Share

  45. SOFOCLEOUS CT, Vasiniotis Kamarinos N
    Tumor Radiation-absorbed Dose: The Missing Link in Radioembolization.
    Radiology. 2020;296:685-686.
    >> Share

    August 2020
  46. KANG HJ, Lee JM, Yoon JH, Lee K, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Radiology. 2020 Aug 25:209017. doi: 10.1148/radiol.2020209017.
    >> Share

  47. ISAAK A, Praktiknjo M, Jansen C, Faron A, et al
    Myocardial Fibrosis and Inflammation in Liver Cirrhosis: MRI Study of the Liver-Heart Axis.
    Radiology. 2020 Aug 18:201057. doi: 10.1148/radiol.2020201057.
    >> Share

  48. ZIV E, Zhang Y, Kelly L, Nikolovski I, et al
    NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation.
    Radiology. 2020 Aug 11:200201. doi: 10.1148/radiol.2020200201.
    >> Share

  49. KANG HJ, Lee JM, Yoon JH, Lee K, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Radiology. 2020 Aug 4:200115. doi: 10.1148/radiol.2020200115.
    >> Share

  50. KIM TK, Jang HJ
    Emerging Evidence of the Utility of Perfluorobutane-enhanced US as a Diagnostic Test for Hepatocellular Carcinoma.
    Radiology. 2020 Aug 4:202763. doi: 10.1148/radiol.2020202763.
    >> Share

    July 2020
  51. PARK S, Joo I, Lee DH, Bae JS, et al
    Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.
    Radiology. 2020 Jul 21:192797. doi: 10.1148/radiol.2020192797.
    >> Share

  52. SAVIC LJ, Doemel LA, Schobert IT, Montgomery RR, et al
    Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?
    Radiology. 2020 Jul 7:200373. doi: 10.1148/radiol.2020200373.
    >> Share

    June 2020
  53. SCHOOLER GR, Squires JH, Alazraki A, Chavhan GB, et al
    Pediatric Hepatoblastoma, Hepatocellular Carcinoma, and Other Hepatic Neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group.
    Radiology. 2020 Jun 30:200751. doi: 10.1148/radiol.2020200751.
    >> Share

  54. HERMANN AL, Dieudonne A, Ronot M, Sanchez M, et al
    Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with (90)Y in the SARAH Study.
    Radiology. 2020 Jun 30:191606. doi: 10.1148/radiol.2020191606.
    >> Share

  55. SUGIMOTO K, Moriyasu F, Oshiro H, Takeuchi H, et al
    The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis.
    Radiology. 2020 Jun 23:192665. doi: 10.1148/radiol.2020192665.
    >> Share

  56. BARR RG, Wilson SR, Rubens D, Garcia-Tsao G, et al
    Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement.
    Radiology. 2020 Jun 9:192437. doi: 10.1148/radiol.2020192437.
    >> Share

    Treat or Wait? Hepatobiliary Phase Hypointense Nodule without Arterial Phase Hyperenhancement.
    Radiology. 2020 Jun 2:201726. doi: 10.1148/radiol.2020201726.
    >> Share

  58. JOO I, Kim SY, Kang TW, Kim YK, et al
    Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
    Radiology. 2020 Jun 2:192275. doi: 10.1148/radiol.2020192275.
    >> Share

    May 2020
  59. GIORGIO A, De Luca M, Gatti P, Matteucci P, et al
    CEUS LI-RADS Categories to Distinguish Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma Malignancies.
    Radiology. 2020 May 12:200623. doi: 10.1148/radiol.2020200623.
    >> Share

  60. LOCKHART ME, Smith AD
    Fatty Liver Disease: Artificial Intelligence Takes on the Challenge.
    Radiology. 2020;295:351-352.
    >> Share

    April 2020
  61. ZHOU IY, Clavijo Jordan V, Rotile NJ, Akam E, et al
    Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis.
    Radiology. 2020 Apr 28:192118. doi: 10.1148/radiol.2020192118.
    >> Share

    March 2020
  62. MULE S, Galletto Pregliasco A, Tenenhaus A, Kharrat R, et al
    Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
    Radiology. 2020 Mar 31:192230. doi: 10.1148/radiol.2020192230.
    >> Share

  63. VERNUCCIO F, Ronot M, Dioguardi Burgio M, Cauchy F, et al
    Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
    Radiology. 2020 Mar 17:191790. doi: 10.1148/radiol.2020191790.
    >> Share

  64. LYSKE J, Hutchinson C, Manolea F, Patel VH, et al
    Case 275: Multiple Hepatic Hydatid Cysts.
    Radiology. 2020;294:716-719.
    >> Share

    February 2020
  65. HAN A, Byra M, Heba E, Andre MP, et al
    Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.
    Radiology. 2020 Feb 25:191160. doi: 10.1148/radiol.2020191160.
    >> Share

  66. KONO Y, Sirlin CB, Fetzer DT, Kim TK, et al
    Time to Clarify Common Misconceptions about the Liver Imaging Reporting and Data System for Contrast-enhanced US.
    Radiology. 2020 Feb 18:192557. doi: 10.1148/radiol.2020192557.
    >> Share

  67. KROMREY ML, Le Bihan D, Ichikawa S, Motosugi U, et al
    Diffusion-weighted MRI-based Virtual Elastography for the Assessment of Liver Fibrosis.
    Radiology. 2020 Feb 11:191498. doi: 10.1148/radiol.2020191498.
    >> Share

  68. KIM MJ
    Improving Survival with Gadoxetic Acid-enhanced MRI for Hepatocellular Carcinoma.
    Radiology. 2020 Feb 4:192713. doi: 10.1148/radiol.2020192713.
    >> Share

  69. HAN A, Zhang YN, Boehringer AS, Montes V, et al
    Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
    Radiology. 2020 Feb 4:191152. doi: 10.1148/radiol.2020191152.
    >> Share

  70. KANG TW, Kong SY, Kang D, Kang MW, et al
    Use of Gadoxetic Acid-enhanced Liver MRI and Mortality in More than 30 000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis.
    Radiology. 2020 Feb 4:190639. doi: 10.1148/radiol.2020190639.
    >> Share

  71. DO RK, Mendiratta-Lala M
    LI-RADS Version 2018 Treatment Response Algorithm: The Evidence Is Accumulating.
    Radiology. 2020;294:327-328.
    >> Share

    January 2020
  72. JI GW, Zhu FP, Xu Q, Wang K, et al
    Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
    Radiology. 2020 Jan 14:191470. doi: 10.1148/radiol.2020191470.
    >> Share

    December 2019
  73. LIAO H, Ahmed M, Markezana A, Zeng G, et al
    Thermal Ablation Induces Transitory Metastatic Growth by Means of the STAT3/c-Met Molecular Pathway in an Intrahepatic Colorectal Cancer Mouse Model.
    Radiology. 2019 Dec 17:191023. doi: 10.1148/radiol.2019191023.
    >> Share

  74. CHAUDHRY M, McGinty KA, Mervak B, Lerebours R, et al
    The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.
    Radiology. 2019 Dec 17:191581. doi: 10.1148/radiol.2019191581.
    >> Share

    Toward Final Rescue of Contrast-enhanced US for the Diagnosis of Hepatocellular Carcinoma.
    Radiology. 2019 Dec 3:192309. doi: 10.1148/radiol.2019192309.
    >> Share

  76. YOON JH, Lee JM, Chang W, Kang HJ, et al
    Initial M Staging of Rectal Cancer: FDG PET/MRI with a Hepatocyte-specific Contrast Agent versus Contrast-enhanced CT.
    Radiology. 2019 Dec 3:190794. doi: 10.1148/radiol.2019190794.
    >> Share

  77. HUANG JY, Li JW, Lu Q, Luo Y, et al
    Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Radiology. 2019 Dec 3:191086. doi: 10.1148/radiol.2019191086.
    >> Share

  78. KIM KW, Van den Abbeele AD
    Evolution of Transarterial Chemoembolization for the Treatment of Liver Cancer.
    Radiology. 2019;293:704-706.
    >> Share

  79. DURAN R, Namur J, Pascale F, Czuczman P, et al
    Vandetanib-eluting Radiopaque Beads: Pharmacokinetics, Safety, and Efficacy in a Rabbit Model of Liver Cancer.
    Radiology. 2019;293:695-703.
    >> Share

    November 2019
  80. SIDHU PS
    Using Contrast-enhanced US for Hepatocellular Carcinoma Assessment: Contrast-enhanced US LI-RADS version 2017 Classification Is Diagnostically Accurate.
    Radiology. 2019 Nov 26:192355. doi: 10.1148/radiol.2019192355.
    >> Share

  81. BASTATI N, Beer L, Mandorfer M, Poetter-Lang S, et al
    Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
    Radiology. 2019 Nov 19:190734. doi: 10.1148/radiol.2019190734.
    >> Share

    October 2019
    Complex Therapeutic Strategies for Hepatocellular Carcinoma: Expanding Criteria.
    Radiology. 2019 Oct 22:192151. doi: 10.1148/radiol.2019192151.
    >> Share

  83. SHI F, Wu M, Lian SS, Mo ZQ, et al
    Radiofrequency Ablation Following Downstaging of Hepatocellular Carcinoma by Using Transarterial Chemoembolization: Long-term Outcomes.
    Radiology. 2019 Oct 22:181991. doi: 10.1148/radiol.2019181991.
    >> Share

    Improving Postsurgical Outcome in Patients with HCC by Using a Hepatobiliary Contrast Agent.
    Radiology. 2019 Oct 8:191990. doi: 10.1148/radiol.2019191990.
    >> Share

  85. KIM DK, An C, Chung YE, Choi JY, et al
    Hepatobiliary versus Extracellular MRI Contrast Agents in Hepatocellular Carcinoma Detection: Hepatobiliary Phase Features in Relation to Disease-free Survival.
    Radiology. 2019 Oct 8:190414. doi: 10.1148/radiol.2019190414.
    >> Share

  86. MEYER M, Ronald J, Vernuccio F, Nelson RC, et al
    Reproducibility of CT Radiomic Features within the Same Patient: Influence of Radiation Dose and CT Reconstruction Settings.
    Radiology. 2019 Oct 1:190928. doi: 10.1148/radiol.2019190928.
    >> Share

  87. QUAIA E
    State of the Art: LI-RADS for Contrast-enhanced US.
    Radiology. 2019;293:4-14.
    >> Share

    September 2019
  88. GRAFFY PM, Sandfort V, Summers RM, Pickhardt PJ, et al
    Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment.
    Radiology. 2019 Sep 17:190512. doi: 10.1148/radiol.2019190512.
    >> Share

  89. LEE DH, Lee JY, Bae JS, Yi NJ, et al
    Shear-Wave Dispersion Slope from US Shear-Wave Elastography: Detection of Allograft Damage after Liver Transplantation.
    Radiology. 2019 Sep 10:190064. doi: 10.1148/radiol.2019190064.
    >> Share

  90. VIJ A, Fetzer DT
    Persistent Heterogeneous Liver Enhancement after US Contrast Material Injection.
    Radiology. 2019;292:539.
    >> Share

    August 2019
  91. GONSALVES CF, Eschelman DJ, Adamo RD, Anne PR, et al
    A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.
    Radiology. 2019 Aug 27:190199. doi: 10.1148/radiol.2019190199.
    >> Share

  92. ALVES PEREIRA FD, Hickson ML, Wilson PAJ
    Case 268: Bilateral Adrenal Hemorrhage in the Context of Sepsis.
    Radiology. 2019;292:503-506.
    >> Share

    July 2019
  93. JONDAL DE, Thompson SM, Butters KA, Knudsen BE, et al
    Single-Dose Neoadjuvant AKT Pathway Inhibitor Reduces Growth of Hepatocellular Carcinoma after Laser Thermal Ablation in Small-Animal Model.
    Radiology. 2019 Jul 23:190115. doi: 10.1148/radiol.2019190115.
    >> Share

  94. WHITE SB
    Treatment of Hepatocellular Carcinoma:Time for a Paradigm Shift?
    Radiology. 2019 Jul 23:191474. doi: 10.1148/radiol.2019191474.
    >> Share

  95. LEE SM, Lee JM, Ahn SJ, Kang HJ, et al
    LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.
    Radiology. 2019 Jul 16:182867. doi: 10.1148/radiol.2019182867.
    >> Share

  96. PARK JH, Park MS, Lee SJ, Jeong WK, et al
    Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
    Radiology. 2019 Jul 9:190183. doi: 10.1148/radiol.2019190183.
    >> Share

  97. KIM DH, Choi SH, Kim SY, Kim MJ, et al
    Gadoxetic Acid-enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases.
    Radiology. 2019;292:270.
    >> Share

    LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.
    Radiology. 2019;292:235-236.
    >> Share

  99. SHROPSHIRE EL, Chaudhry M, Miller CM, Allen BC, et al
    LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.
    Radiology. 2019;292:226-234.
    >> Share

    June 2019
  100. MILOT L
    Does Hepatocellular Carcinoma Screening with US Work? Using the US LI-RADS Algorithm.
    Radiology. 2019 Jun 18:191105. doi: 10.1148/radiol.2019191105.
    >> Share

  101. SON JH, Choi SH, Kim SY, Jang HY, et al
    Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
    Radiology. 2019 Jun 18:190035. doi: 10.1148/radiol.2019190035.
    >> Share

  102. PADIA SA
    Is Idarubicin the Future of TACE?
    Radiology. 2019;291:809-810.
    >> Share

  103. FOWLER KJ, Sirlin CB
    Is It Time to Expand the Definition of Washout Appearance in LI-RADS?
    Radiology. 2019;291:658-659.
    >> Share

    May 2019
  104. MALLOY PC
    Combination Therapy in Intermediate-Stage Hepatocellular Carcinoma: Do We Need to Know about Microvascular Invasion?
    Radiology. 2019 May 28:190921. doi: 10.1148/radiol.2019190921.
    >> Share

  105. PENG Z, Chen S, Xiao H, Wang Y, et al
    Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Radiology. 2019 May 28:181818. doi: 10.1148/radiol.2019181818.
    >> Share

    Probing the Liver-Heart Axis.
    Radiology. 2019;291:338-339.
    >> Share

    April 2019
  107. GUIU B, Chevallier P, Assenat E, Barbier E, et al
    Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial.
    Radiology. 2019 Apr 30:182399. doi: 10.1148/radiol.2019182399.
    >> Share

  108. KIM DH, Choi SH, Kim SY, Kim MJ, et al
    Gadoxetic Acid-enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases.
    Radiology. 2019 Apr 16:182587. doi: 10.1148/radiol.2019182587.
    >> Share

  109. FURLAN A
    New Progress toward Validation of LI-RADS Version 2018.
    Radiology. 2019;291:81-82.
    >> Share

    March 2019
  110. VITA T, Murphy DJ, Osborne MT, Bajaj NS, et al
    Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT.
    Radiology. 2019 Mar 5:181793. doi: 10.1148/radiol.2019181793.
    >> Share

  111. LUCATELLI P, De Rubeis G, Rocco B, Bezzi M, et al
    Are Radiopaque Beads a Real Advantage?
    Radiology. 2019;290:852-853.
    >> Share

    January 2019
  112. KIM YY, Kim MJ, Kim EH, Roh YH, et al
    Hepatocellular Carcinoma versus Other Hepatic Malignancy in Cirrhosis: Performance of LI-RADS Version 2018.
    Radiology. 2019 Jan 29:181995. doi: 10.1148/radiol.2019181995.
    >> Share

  113. HEERINK WJ, Ruiter SJS, Pennings JP, Lansdorp B, et al
    Robotic versus Freehand Needle Positioning in CT-guided Ablation of Liver Tumors: A Randomized Controlled Trial.
    Radiology. 2019 Jan 22:181698. doi: 10.1148/radiol.2018181698.
    >> Share

  114. GRAY MD, Lyon PC, Mannaris C, Folkes LK, et al
    Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial.
    Radiology. 2019 Jan 15:181445. doi: 10.1148/radiol.2018181445.
    >> Share

  115. YOON JH, Lee JM
    Can MRI Features Predict Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma?
    Radiology. 2019 Jan 8:182775. doi: 10.1148/radiol.2018182775.
    >> Share

  116. MIN JH, Kim YK, Choi SY, Kang TW, et al
    Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis.
    Radiology. 2019 Jan 8:181485. doi: 10.1148/radiol.2018181485.
    >> Share

    December 2018
  117. POOLER BD, Wiens CN, McMillan A, Artz NS, et al
    Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study.
    Radiology. 2018 Dec 18:181134. doi: 10.1148/radiol.2018181134.
    >> Share

  118. WESTON AD, Korfiatis P, Kline TL, Philbrick KA, et al
    Automated Abdominal Segmentation of CT Scans for Body Composition Analysis Using Deep Learning.
    Radiology. 2018 Dec 11:181432. doi: 10.1148/radiol.2018181432.
    >> Share

  119. CURTIS WA, Fraum TJ, An H, Chen Y, et al
    Quantitative MRI of Diffuse Liver Disease: Current Applications and Future Directions.
    Radiology. 2018 Dec 4:172765. doi: 10.1148/radiol.2018172765.
    >> Share

  120. PARK HJ, Lee SS, Park B, Yun J, et al
    Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis.
    Radiology. 2018 Dec 4:181197. doi: 10.1148/radiol.2018181197.
    >> Share

    November 2018
  121. JENSEN CT, Wagner-Bartak NA, Vu LN, Liu X, et al
    Detection of Colorectal Hepatic Metastases Is Superior at Standard Radiation Dose CT versus Reduced Dose CT.
    Radiology. 2018 Nov 27:181657. doi: 10.1148/radiol.2018181657.
    >> Share

  122. QI X, An W, Liu F, Qi R, et al
    Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension.
    Radiology. 2018 Nov 20:180425. doi: 10.1148/radiol.2018180425.
    >> Share

    Virtual Hepatic Venous Pressure Gradient with CT: Ready for Prime Time?
    Radiology. 2018 Nov 20:182351. doi: 10.1148/radiol.2018182351.
    >> Share

  124. BASHIR MR, Chernyak V
    Can MRI Features of Combined Hepatocellular Carcinoma-Intrahepatic Cholangiogarcinoma Help Predict Tumor Behavior Better than Histologic Findings?
    Radiology. 2018 Nov 13:182408. doi: 10.1148/radiol.2018182408.
    >> Share

  125. CHOI SH, Lee SS, Park SH, Kim KM, et al
    LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI.
    Radiology. 2018 Nov 13:181290. doi: 10.1148/radiol.2018181290.
    >> Share

    October 2018
  126. YOON JH, Lee JM, Kang HJ, Ahn SJ, et al
    Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio.
    Radiology. 2018 Oct 30:180753. doi: 10.1148/radiol.2018180753.
    >> Share

  127. MOTOSUGI U, Roldan-Alzate A, Bannas P, Said A, et al
    Four-dimensional Flow MRI as a Marker for Risk Stratification of Gastroesophageal Varices in Patients with Liver Cirrhosis.
    Radiology. 2018 Oct 16:180230. doi: 10.1148/radiol.2018180230.
    >> Share

  128. KHALAF MH, Sundaram V, AbdelRazek Mohammed MA, Shah R, et al
    A Predictive Model for Postembolization Syndrome after Transarterial Hepatic Chemoembolization of Hepatocellular Carcinoma.
    Radiology. 2018 Oct 9:180257. doi: 10.1148/radiol.2018180257.
    >> Share

    September 2018
  129. CHERNYAK V, Fowler KJ, Kamaya A, Kielar AZ, et al
    Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.
    Radiology. 2018 Sep 25:181494. doi: 10.1148/radiol.2018181494.
    >> Share

  130. FLETCHER JG, Fidler JL, Venkatesh S, Hough DM, et al
    Observer Performance with Varying Radiation Dose and Reconstruction Methods for Detection of Hepatic Metastases.
    Radiology. 2018 Sep 11:180125. doi: 10.1148/radiol.2018180125.
    >> Share

  131. SARTORIS R, Rautou PE, Elkrief L, Pollorsi G, et al
    Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension.
    Radiology. 2018 Sep 4:181131. doi: 10.1148/radiol.2018181131.
    >> Share

  132. BASTIAANNET R, van Roekel C, Kunnen B, Lam MGEH, et al
    Is Diffusion-weighted MRI Really Superior to PET/CT in Predicting Survival after Radioembolization?
    Radiology. 2018 Sep 4:181348. doi: 10.1148/radiol.2018181348.
    >> Share

  133. SMITH AD
    Enter the Era of Quantitative Liver CT.
    Radiology. 2018 Sep 4:181847. doi: 10.1148/radiol.2018181847.
    >> Share

  134. CHOI KJ, Jang JK, Lee SS, Sung YS, et al
    Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver.
    Radiology. 2018 Sep 4:180763. doi: 10.1148/radiol.2018180763.
    >> Share

    August 2018
  135. PANDEY A, Pandey P, Ghasabeh MA, Zarghampour M, et al
    Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization?
    Radiology. 2018 Aug 21:180450. doi: 10.1148/radiol.2018180450.
    >> Share

  136. CHUNG JW, Kim HC
    Can CT Following Chemoembolization with Radiopaque Drug-Eluting Beads Tell Us How Much Drug We Deliver?
    Radiology. 2018 Aug 14:181275. doi: 10.1148/radiol.2018181275.
    >> Share

  137. MIKHAIL AS, Pritchard WF, Negussie AH, Krishnasamy VP, et al
    Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model.
    Radiology. 2018 Aug 14:172571. doi: 10.1148/radiol.2018172571.
    >> Share

    July 2018
  138. BARR RG
    Liver Elastography Still in Its Infancy.
    Radiology. 2018;288:107-108.
    >> Share

  139. HUDERT CA, Tzschatzsch H, Guo J, Rudolph B, et al
    US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver Disease.
    Radiology. 2018;288:99-106.
    >> Share

    June 2018
  140. LUETKENS JA, Klein S, Traber F, Schmeel FC, et al
    Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results.
    Radiology. 2018 Jun 26:180051. doi: 10.1148/radiol.2018180051.
    >> Share

  141. JOHNSON PT, Fishman EK
    Hereditary Hemorrhagic Telangiectasia: Cinematic Rendering of Hepatic Arteriovenous Malformations.
    Radiology. 2018 Jun 19:180380. doi: 10.1148/radiol.2018180380.
    >> Share

  142. HEVERHAGEN JT, Kudrnova S
    Subcentimeter Hepatocellular Carcinoma: A New Paradigm for Treatment with Percutaneous Radiofrequency Ablation?
    Radiology. 2018 Jun 19:180977. doi: 10.1148/radiol.2018180977.
    >> Share

  143. SONG KD, Lee MW, Rhim H, Kang TW, et al
    Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Radiology. 2018 Jun 19. doi: 10.1148/radiol.2018172743.
    >> Share

  144. BREHMER K, Brismar TB, Morsbach F, Svensson A, et al
    Triple Arterial Phase CT of the Liver with Radiation Dose Equivalent to That of Single Arterial Phase CT: Initial Experience.
    Radiology. 2018 Jun 19:172875. doi: 10.1148/radiol.2018172875.
    >> Share

  145. JOO I, Lee JM, Yoon JH
    Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.
    Radiology. 2018 Jun 5:171187. doi: 10.1148/radiol.2018171187.
    >> Share

  146. FANG C, Jaffer OS, Yusuf GT, Konstantatou E, et al
    Reducing the Number of Measurements in Liver Point Shear-Wave Elastography: Factors that Influence the Number and Reliability of Measurements in Assessment of Liver Fibrosis in Clinical Practice.
    Radiology. 2018;287:844-852.
    >> Share

  147. TROUT AT, Sheridan RM, Serai SD, Xanthakos SA, et al
    Diagnostic Performance of MR Elastography for Liver Fibrosis in Children and Young Adults with a Spectrum of Liver Diseases.
    Radiology. 2018;287:824-832.
    >> Share

    May 2018
  148. BARABASCH A, Heinzel A, Bruners P, Kraemer NA, et al
    Diffusion-weighted MRI Is Superior to PET/CT in Predicting Survival of Patients Undergoing (90)Y Radioembolization of Hepatic Metastases.
    Radiology. 2018 May 21:170408. doi: 10.1148/radiol.2018170408.
    >> Share

  149. DEVULAPALLI KK, Fidelman N, Soulen MC, Miller M, et al
    (90)Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections.
    Radiology. 2018 May 8:170962. doi: 10.1148/radiol.2018170962.
    >> Share

  150. JONDAL DE, Thompson SM, Butters KA, Knudsen BE, et al
    Heat Stress and Hepatic Laser Thermal Ablation Induce Hepatocellular Carcinoma Growth: Role of PI3K/mTOR/AKT Signaling.
    Radiology. 2018 May 8:172944. doi: 10.1148/radiol.2018172944.
    >> Share

    Radiofrequency Ablation versus Resection for Small Hepatocellular Carcinoma: Are Randomized Controlled Trials Still Needed?
    Radiology. 2018;287:473-475.
    >> Share

  152. POMPER MG, Lee S
    Molecularly Targeted MR Imaging Agent in Liver Fibrosis: High Sensitivity and Low Gadolinium Mean High Translational Potential.
    Radiology. 2018;287:590-591.
    >> Share

    April 2018
    Radiation Segmentectomy for Hepatocellular Carcinoma: Ready for Prime Time?
    Radiology. 2018 Apr 24:180163. doi: 10.1148/radiol.2018180163.
    >> Share

  154. LEWANDOWSKI RJ, Gabr A, Abouchaleh N, Ali R, et al
    Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma.
    Radiology. 2018 Apr 24:171768. doi: 10.1148/radiol.2018171768.
    >> Share

  155. ZHU K, Huang J, Lai L, Huang W, et al
    Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation.
    Radiology. 2018 Apr 24:172028. doi: 10.1148/radiol.2018172028.
    >> Share

  156. CERNY M, Bergeron C, Billiard JS, Murphy-Lavallee J, et al
    LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma: Performance of Major and Ancillary Features.
    Radiology. 2018 Apr 10:171678. doi: 10.1148/radiol.2018171678.
    >> Share

  157. SHYN PB, Casadaban LC, Sainani NI, Sadow CA, et al
    Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
    Radiology. 2018 Apr 3:172108. doi: 10.1148/radiol.2018172108.
    >> Share

  158. WANG X, Su Z, Lyu T, Figini M, et al
    (18)F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model.
    Radiology. 2018;287:137-145.
    >> Share

    March 2018
  159. MULE S, Thiefin G, Costentin C, Durot C, et al
    Advanced Hepatocellular Carcinoma: Pretreatment Contrast-enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated with Sorafenib.
    Radiology. 2018 Mar 27:171320. doi: 10.1148/radiol.2018171320.
    >> Share

  160. PANDEY A, Pandey P, Aliyari Ghasabeh M, Najmi Varzaneh F, et al
    Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival.
    Radiology. 2018 Mar 27:171593. doi: 10.1148/radiol.2018171593.
    >> Share

  161. TA CN, Kono Y, Eghtedari M, Oh YT, et al
    Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings.
    Radiology. 2018;286:1062-1071.
    >> Share

    February 2018
  162. CHOI SH, Byun JH, Lim YS, Lee SJ, et al
    Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules.
    Radiology. 2018 Feb 19:170748. doi: 10.1148/radiol.2018170748.
    >> Share

  163. PENG Z, Chen S, Wei M, Lin M, et al
    Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Radiology. 2018 Feb 1:171541. doi: 10.1148/radiol.2018171541.
    >> Share

  164. MURALI N, Laage-Gaupp FM, Chapiro J, Geschwind JF, et al
    Science to Practice: Decrypting the Enigma of Ablation-induced Off-Target Effects-Is Network Pathway Analysis the Final Piece of the Puzzle?
    Radiology. 2018;286:405-408.
    >> Share

  165. BOESCH C
    Quantitative MR Imaging Is Increasingly Important in Liver Disease.
    Radiology. 2018;286:557-559.
    >> Share

    January 2018
  166. KWEE SA, Wong L, Chan OTM, Kalathil S, et al
    PET/CT with (18)F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer.
    Radiology. 2018 Jan 9:171333. doi: 10.1148/radiol.2018171333.
    >> Share

  167. LEE DH, Lee JM, Kang TW, Rhim H, et al
    Clinical Outcomes of Radiofrequency Ablation for Early Hypovascular HCC: A Multicenter Retrospective Study.
    Radiology. 2018;286:338-349.
    >> Share

    December 2017
  168. YU SCH, Chan SL, Lee KF, Hui JWY, et al
    Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization.
    Radiology. 2017 Dec 22:170154. doi: 10.1148/radiol.2017170154.
    >> Share

  169. YASAKA K, Akai H, Kunimatsu A, Abe O, et al
    Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images.
    Radiology. 2017 Dec 14:171928. doi: 10.1148/radiol.2017171928.
    >> Share

  170. SANDOW TA, Arndt SE, Albar AA, DeVun DA, et al
    Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort.
    Radiology. 2017 Dec 4:170731. doi: 10.1148/radiol.2017170731.
    >> Share

  171. SHAMIR SB, Kurian J, Kogan-Liberman D, Taragin BH, et al
    Hepatic Imaging in Neonates and Young Infants: State of the Art.
    Radiology. 2017;285:763-777.
    >> Share

  172. YANG X
    Science to Practice: Enhancing Photothermal Ablation of Colorectal Liver Metastases with Targeted Hybrid Nanoparticles.
    Radiology. 2017;285:699-701.
    >> Share

  173. WHITE SB, Kim DH, Guo Y, Li W, et al
    Biofunctionalized Hybrid Magnetic Gold Nanoparticles as Catalysts for Photothermal Ablation of Colorectal Liver Metastases.
    Radiology. 2017;285:809-819.
    >> Share

    November 2017
  174. CHOI SY, Kim SH, Park CK, Min JH, et al
    Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
    Radiology. 2017 Nov 21:162846. doi: 10.1148/radiol.2017162846.
    >> Share

  175. TANG A, Bashir MR, Corwin MT, Cruite I, et al
    Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
    Radiology. 2017 Nov 21:170554. doi: 10.1148/radiol.2017170554.
    >> Share

  176. FARRAR CT, Gale EM, Kennan R, Ramsay I, et al
    CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis.
    Radiology. 2017 Nov 20:170595. doi: 10.1148/radiol.2017170595.
    >> Share

  177. XU XL, Liu XD, Liang M, Luo BM, et al
    Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis.
    Radiology. 2017 Nov 13:162756. doi: 10.1148/radiol.2017162756.
    >> Share

  178. SEROR O, Nault JC, N'Kontchou G, Sutter O, et al
    Is "Segmentectomy" a Suitable Term to Use in Patients Undergoing Hepatic Segmental 90Y Radioembolization for the Treatment of Hepatocellular Carcinoma Up to 3 cm?
    Radiology. 2017;285:690-691.
    >> Share

  179. ADAM LC, Murali N, Chapiro J, Geschwind JF, et al
    Science to Practice: Molecular-targeted Drug Delivery in Combination with Radiofrequency Ablation of Liver Cancer: A Magic Bullet?
    Radiology. 2017;285:333-335.
    >> Share

  180. YAN F, Wang S, Yang W, Goldberg SN, et al
    Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors.
    Radiology. 2017;285:462-471.
    >> Share

  181. FOWLER KJ, Tang A, Santillan C, Bhargavan-Chatfield M, et al
    Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study.
    Radiology. 2017 Nov 1:170376. doi: 10.1148/radiol.2017170376.
    >> Share

    October 2017
  182. YASAKA K, Akai H, Abe O, Kiryu S, et al
    Deep Learning with Convolutional Neural Network for Differentiation of Liver Masses at Dynamic Contrast-enhanced CT: A Preliminary Study.
    Radiology. 2017 Oct 27:170706. doi: 10.1148/radiol.2017170706.
    >> Share

    September 2017
  183. WANG WT, Yang L, Yang ZX, Hu XX, et al
    Assessment of Microvascular Invasion of Hepatocellular Carcinoma with Diffusion Kurtosis Imaging.
    Radiology. 2017 Sep 22:170515. doi: 10.1148/radiol.2017170515.
    >> Share

  184. RUNGE JH, Smits LP, Verheij J, Depla A, et al
    MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
    Radiology. 2017 Sep 15:162931. doi: 10.1148/radiol.2017162931.
    >> Share

  185. YOKOO T, Serai SD, Pirasteh A, Bashir MR, et al
    Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.
    Radiology. 2017 Sep 11:170550. doi: 10.1148/radiol.2017170550.
    >> Share

  186. KUMAR G, Goldberg SN, Gourevitch S, Levchenko T, et al
    Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.
    Radiology. 2017 Sep 6:162943. doi: 10.1148/radiol.2017162943.
    >> Share

    August 2017
  187. FRAUM TJ, Tsai R, Rohe E, Ludwig DR, et al
    Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014.
    Radiology. 2017 Aug 29:170114. doi: 10.1148/radiol.2017170114.
    >> Share

  188. DISTELMAIER M, Barabasch A, Heil P, Kraemer NA, et al
    Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Radiology. 2017 Aug 11:161561. doi: 10.1148/radiol.2017161561.
    >> Share

  189. RONALD J, Nixon AB, Marin D, Gupta RT, et al
    Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.
    Radiology. 2017 Aug 8:162555. doi: 10.1148/radiol.2017162555.
    >> Share

  190. WAGNER M, Corcuera-Solano I, Lo G, Esses S, et al
    Technical Failure of MR Elastography Examinations of the Liver: Experience from a Large Single-Center Study.
    Radiology. 2017;284:401-412.
    >> Share

    July 2017
  191. LV Y, He C, Wang Z, Guo W, et al
    Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis.
    Radiology. 2017 Jul 5:162266. doi: 10.1148/radiol.2017162266.
    >> Share

  192. LEE JM
    Old and New MR Tools to Measure Hepatic Steatosis: Is Their Diagnostic Accuracy the Same?
    Radiology. 2017;284:303-304.
    >> Share

  193. HARZ C, Schockel L, Endrikat J, Pietsch H, et al
    Signal Intensity Increase in the Central Nervous System after Previous Gadoxetic Acid-enhanced MR Imaging.
    Radiology. 2017;284:299-301.
    >> Share

    June 2017
  194. KIM BR, Lee JM, Lee DH, Yoon JH, et al
    Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma.
    Radiology. 2017 Jun 13:162080. doi: 10.1148/radiol.2017162080.
    >> Share

  195. LEE DH, Lee JY, Lee KB, Han JK, et al
    Evaluation of Hepatic Steatosis by Using Acoustic Structure Quantification US in a Rat Model: Comparison with Pathologic Examination and MR Spectroscopy.
    Radiology. 2017 Jun 13:161923. doi: 10.1148/radiol.2017161923.
    >> Share

  196. GOSHIMA S, Bae KT
    Liver Surface Nodularity as a Biomarker for Detection and Evaluation of Cirrhosis.
    Radiology. 2017;283:921-922.
    >> Share

  197. CHEN BB, Hsu CY, Yu CW, Liang PC, et al
    Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
    Radiology. 2017;283:923.
    >> Share

  198. SAVIC LJ, Chapiro J, Geschwind JF
    Science to Practice: Killing Dormant Cells-Is Targeting Autophagy the Key to Complete Tumor Response in Transarterial Chemoembolization?
    Radiology. 2017;283:621-623.
    >> Share

  199. GARCOVICH M, Veraldi S, Di Stasio E, Zocco MA, et al
    Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography.
    Radiology. 2017;283:820-827.
    >> Share

    May 2017
  200. KAO WY, Su CW, Chiou YY, Chiu NC, et al
    Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation.
    Radiology. 2017 May 30:162382. doi: 10.1148/radiol.2017162382.
    >> Share

  201. WIDYA RL, de Mutsert R, Westenberg JJM, Gast KB, et al
    Is Hepatic Triglyceride Content Associated with Aortic Pulse Wave Velocity and Carotid Intima-Media Thickness? The Netherlands Epidemiology of Obesity Study.
    Radiology. 2017 May 29:160916. doi: 10.1148/radiol.2017160916.
    >> Share

  202. LEE KS, Santagostino SF, Li D, Ramjit A, et al
    Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis.
    Radiology. 2017 May 11:162617. doi: 10.1148/radiol.2017162617.
    >> Share

  203. KUHN JP, Meffert P, Heske C, Kromrey ML, et al
    Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.
    Radiology. 2017 May 5. doi: 10.1148/radiol.2017161228.
    >> Share

    April 2017
  204. SUTTER O, Calvo J, N'Kontchou G, Nault JC, et al
    Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
    Radiology. 2017 Apr 28:161413. doi: 10.1148/radiol.2017161413.
    >> Share

  205. CHEN R, Li J, Zhou X, Liu J, et al
    Fructose-1,6-Bisphosphatase 1 Reduces 18F FDG Uptake in Hepatocellular Carcinoma.
    Radiology. 2017 Apr 6:161607. doi: 10.1148/radiol.2017161607.
    >> Share

  206. ETCHELL E, Juge L, Hatt A, Sinkus R, et al
    Liver Stiffness Values Are Lower in Pediatric Subjects than in Adults and Increase with Age: A Multifrequency MR Elastography Study.
    Radiology. 2017;283:222-230.
    >> Share

    March 2017
  207. PULLI B, Wojtkiewicz G, Iwamoto Y, Ali M, et al
    Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.
    Radiology. 2017 Mar 30:160588. doi: 10.1148/radiol.2017160588.
    >> Share

  208. PARK MJ, Hong N, Han K, Kim MJ, et al
    Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Radiology. 2017 Mar 22:161619. doi: 10.1148/radiol.2017161619.
    >> Share

    February 2017
  209. HYODO T, Yada N, Hori M, Maenishi O, et al
    Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Clinical Evaluation.
    Radiology. 2017 Feb 17:160130. doi: 10.1148/radiol.2017160130.
    >> Share

  210. SOLOMON J, Marin D, Roy Choudhury K, Patel B, et al
    Effect of Radiation Dose Reduction and Reconstruction Algorithm on Image Noise, Contrast, Resolution, and Detectability of Subtle Hypoattenuating Liver Lesions at Multidetector CT: Filtered Back Projection versus a Commercial Model-based Iterative Rec
    Radiology. 2017 Feb 7:161736. doi: 10.1148/radiol.2017161736.
    >> Share

  211. MICHEL LS, Dyroff S, Brooks FJ, Spayd KJ, et al
    PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.
    Radiology. 2017;282:453-463.
    >> Share

    December 2016
  212. KIM YK, Lin WC, Sung K, Raman SS, et al
    Reducing Artifacts during Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging: Dilution Method versus Reduced Injection Rate.
    Radiology. 2016 Dec 15:160241.
    >> Share

  213. BELLINI D, Ramirez-Giraldo JC, Bibbey A, Solomon J, et al
    Dual-Source Single-Energy Multidetector CT Used to Obtain Multiple Radiation Exposure Levels within the Same Patient: Phantom Development and Clinical Validation.
    Radiology. 2016 Dec 5:161233.
    >> Share

    November 2016
  214. SAHU S, Schernthaner R, Ardon R, Chapiro J, et al
    Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?
    Radiology. 2016 Nov 10:160838.
    >> Share

    October 2016
  215. SERAI SD, Dillman JR, Trout AT
    Spin-echo Echo-planar Imaging MR Elastography versus Gradient-echo MR Elastography for Assessment of Liver Stiffness in Children and Young Adults Suspected of Having Liver Disease.
    Radiology. 2016 Oct 10:160589.
    >> Share

    August 2016
  216. HYODO T, Hori M, Lamb P, Sasaki K, et al
    Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Experimental Validation.
    Radiology. 2016 Aug 19:160129.
    >> Share

    June 2016
  217. TROUT AT, Serai S, Mahley AD, Wang H, et al
    Liver Stiffness Measurements with MR Elastography: Agreement and Repeatability across Imaging Systems, Field Strengths, and Pulse Sequences.
    Radiology. 2016 Jun 10:160209.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016